Why the study?
Does simultaneous inhibition of COMT and MAO prolong the cardiovascular effects of injected norepinephrine in anesthetized dogs?
Does simultaneous inhibition of COMT and MAO prolong the cardiovascular effects of injected norepinephrine in anesthetized dogs?
The physiological inactivation of circulating norepinephrine at receptor sites does not require metabolic destruction by COMT and MAO.
Indicates non-metabolic inactivation predominates for circulating norepinephrine; leaves open dominant pathways and human relevance.
The simultaneous inhibition of catechol-O-methyl transferase and monoamine oxidase (by pyrogallol and JB-835) produced only moderate prolongation of the cardiovascular effects of injected l-norepinephrine in anesthetized dogs. This prolongation of pharmacological action in presence of enzyme inhibitors was correlated with a delayed disappearance of injected norepinephrine from the circulation. While these results indicate that metabolism by these enzymes contributes to removal of circulating norepinephrine from the plasma in the dog, they further suggest that the physiological inactivation of circulating norepinephrine at the receptor sites does not require metabolic destruction of the amine by these enzymes.
No takes yet. Share an insight, caveat, or question.
J. Richard Crout (1961) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: